Lawsuits: Lexapro Can Cause Birth Defects

December 11, 2013

Important Information

ClassAction.org is no longer reviewing claims for this case. The information here is for reference only. Up-to-date information and resources can be found here.

Comments |

At A Glance

This Alert Affects:
Women who took Lexapro during pregnancy and delivered children with birth defects.
Injuries:
Birth defects including malformations of the heart, abdomen, or cranium.
Manufacturer:
Forest Labs, Inc.
What is Lexapro?
Lexapro belongs to a group of drugs known as selective serotonin reuptake inhibitors (SSRIs) and is used to treat depression and generalized anxiety disorder.
FDA Warning:
In July 2006, the FDA issued a Public Health Advisory involving Lexapro and other SSRIs. According to the agency, a study suggested that women who use an SSRI after their 20th week of pregnancy are at a higher risk of delivering infants with a life-threatening lung condition known as persistent pulmonary hypertension of the newborn (PPHN).
Type of Lawsuit:
Mass Tort